AirsupraPatient Assistance Program

Introduction

Asthma is a chronic respiratory condition that affects the airways and can make breathing difficult during symptom flare-ups or asthma attacks. Many individuals living with asthma experience symptoms such as wheezing, chest tightness, coughing, and shortness of breath that interfere with daily activities, sleep, exercise, and overall quality of life.

For some patients, asthma symptoms can worsen suddenly and require fast-acting treatment to help open the airways and improve breathing. Rescue inhalers are commonly used to provide quick symptom relief during asthma episodes and help reduce the severity of breathing complications.

Airsupra is a combination rescue inhaler that contains albuterol, a fast-acting bronchodilator, and budesonide, an inhaled corticosteroid that helps reduce airway inflammation. The medication was designed to provide both rapid symptom relief and anti-inflammatory treatment during asthma rescue use.

Airsupra became the first FDA-approved rescue inhaler to combine a short-acting bronchodilator with an inhaled corticosteroid specifically for as-needed asthma treatment in adults. By combining both medications into one inhaler, Airsupra may help reduce the risk of severe asthma exacerbations while also improving short-term breathing relief.

Although asthma treatment plays an important role in symptom management and long-term respiratory health, brand-name inhalers and specialty respiratory medications can become expensive. Insurance limitations, pharmacy pricing, copays, and ongoing prescription costs may create financial stress for patients managing chronic respiratory conditions.

Prescription Hope’s comprehensive medication access service helps patients who qualify access their medication’s patient assistance program. Our advocates work on behalf of patients during the application process, gather required documentation, coordinate with healthcare providers, and offer ongoing support whenever possible.

Through Prescription Hope’s medication access service, patients and families receive guidance and assistance while navigating medication affordability concerns associated with brand-name asthma inhalers like Airsupra.

 

What Is the Airsupra Patient Assistance Program?

When a brand-name medication comes to market, research and development costs, unique manufacturing processes, and external pressures can raise a medication’s retail price beyond what the average American can pay.

Because of this reality, the pharmaceutical manufacturers have developed a solution. Often, they launch a Patient Assistance Program. These are available to qualified patients, providing access to affordable medications.

For instance, the Airsupra Patient Assistance Program provides affordable Airsupra to patients who meet certain requirements.

However, many of these patient assistance programs have application processes that can be complex to navigate. They typically require extensive document collection, healthcare provider signatures, perfectly filled-out forms, and direct communication.

This process can make it a painful headache for those already dealing with the complications of serious conditions.

But there is a solution.

 

How Expert Advocates Help Make Airsupra More Affordable

Professional Application Management

Those who have sought out medication access by applying for patient assistance programs understand the difficulties that come with the ordeal.

Prescription Hope advocates on patients’ behalf with the manufacturer’s patient assistance programs every day.

We handle the work so you can have peace of mind and focus on your condition. Our Florida-based, trained staff takes the lead, completing all required forms, collecting necessary documentation, coordinating signatures with healthcare providers, and even managing communication with the manufacturers.

Our service rate of $70.00 per month, per med doesn’t just cover the application process, either.

After approval, our team continues to manage your account; they take care of refill scheduling, update necessary documents, and even handle your required yearly renewals.

All with no additional medication costs.

Predictable Monthly Pricing

Dealing with chronic asthma and its treatment costs can be a massive financial burden on patients and their families.

Many who suffer from chronic asthma desire affordable Airsupra, but struggle to find proper asthma inhaler assistance.

Thankfully, plenty of savings options exist. Things like insurance, financial assistance, discount cards, coupons, and more can all help a person save every month.

But like with anything, there’s a catch. Each option has strengths and weaknesses. Some are unpredictable or offer limited savings. Others have gaps in coverage or available assistance. Deductibles and co-pays can negate any significant savings.

 

Prescription Hope – The Best Option

Prescription Hope is different. We’re not an insurance company, discount card, or coupon. We’re not affiliated with financial assistance or government programs.

We offer a comprehensive medication access service through patient assistance programs.

For $70.00 per month, per medication, our patient advocates work on your behalf for as long as you are a patient with us. That means we handle coordinating with manufacturers, reaching out to healthcare providers if needed, updating documents, and monitoring any changes to your program status.

And if you do not qualify for your intended program, we’ll help find an alternative. Whether a substitute medication and its program, discount card, coupon, or other option – we’ll work to save you money every month.

If we can’t help? You pay nothing.

 

Ongoing Advocacy and Refill Support

We don’t stop once you’ve been approved. We continue to monitor your program status and alert you to any changes that may occur.

Our patient advocates work to keep documents up to date, as any documentation issues may result in disqualification. We also manage refill scheduling, yearly renewals, and more.

 

Airsupra Patient Assistance Eligibility

Those interested in Airsupra eligibility for the Airsupra Patient Assistance Program and looking for affordable asthma medication need to know whether they qualify. While each program maintains its own unique qualification criteria, they generally require at least the following four categories:

Income: Income thresholds vary by program.

Residency: All applicants must be U.S. residents to qualify.

Prescription: Patients may only apply for prescriptions they currently have.

Insurance: Insurance status differs from program to program.

 

Simple Enrollment With Expert Support

Starting Your Journey

Those needing application support on their journey to asthma medication assistance can follow Prescription Hope’s simple 6-step process.

To see if you qualify for the Airsupra Patient Assistance Program:

• Submit Information: Our online enrollment form only takes a few minutes.
• Advocate Contact: Upon completion of your enrollment form, an advocate will contact you within 1-2 business days.
• Document Collection: After we prequalify you, we’ll collect all necessary documents and forms.
• Provider Coordination: We work with your healthcare provider to get the signatures you need.
• Program Submission: Once everything is in order, we submit your application packet and continue to coordinate with the manufacturer throughout the approval process.
• Medication Delivery: After approval, a patient typically sees their medication shipped directly from the manufacturer to their door or doctor’s office within 2 weeks.

Medication Delivery and Ongoing Support

Your medication is delivered directly to your door or doctor’s office from the manufacturer. Prescription Hope does not at any time handle your medication.

However, we do manage the administrative work surrounding your medication access and refill schedule. This leaves you free from thinking about asthma inhaler access or refills. Instead, you get to focus on what matters – quality of life.

 

Understanding Airsupra

How Airsupra Works

Airsupra combines two asthma medications into one rescue inhaler to help provide fast symptom relief while also reducing airway inflammation. The inhaler contains albuterol, a short-acting beta2-agonist bronchodilator, and budesonide, an inhaled corticosteroid.

Albuterol works by quickly relaxing the muscles surrounding the airways, helping open the lungs and improve breathing during asthma symptoms such as wheezing, chest tightness, and shortness of breath. This fast-acting effect may help provide quick relief during asthma flare-ups.

Budesonide works differently by helping reduce inflammation inside the airways. Airway inflammation is a major contributor to asthma symptoms and asthma attacks. By including an inhaled corticosteroid in the rescue inhaler, Airsupra may help reduce the risk of severe asthma exacerbations while treating symptoms at the same time.

This dual-action approach combines immediate bronchodilation with anti-inflammatory treatment in a single inhaler designed for as-needed rescue use in adults with asthma.

 

What Conditions Does Airsupra Treat?

Airsupra is FDA-approved for the as-needed treatment or prevention of bronchoconstriction in adults with asthma. The medication is also approved to help reduce the risk of asthma exacerbations, commonly called asthma attacks, in adults aged 18 years and older.

Asthma is a chronic respiratory condition that causes inflammation and narrowing of the airways. Symptoms may include wheezing, coughing, chest tightness, and shortness of breath that can vary from mild to severe.

Airsupra is intended for rescue use during asthma symptoms rather than as a daily maintenance inhaler. Some patients may still require separate long-term controller medications depending on the severity of their asthma and healthcare provider recommendations.

Because worsening asthma symptoms may increase the risk of emergency healthcare visits and serious breathing complications, patients are generally advised to monitor rescue inhaler use and report worsening asthma control to their healthcare provider.

 

Benefits of Treatment

Airsupra may help provide rapid relief of asthma symptoms such as wheezing, chest tightness, and shortness of breath while also helping reduce airway inflammation. By combining a rescue bronchodilator with an inhaled corticosteroid, the medication may help lower the risk of severe asthma exacerbations in some patients.

For adults with asthma, reducing inflammation during rescue inhaler use may help improve overall asthma symptom control and potentially decrease emergency asthma-related healthcare visits. The combination approach may also provide added protection compared to rescue bronchodilator use alone.

Because Airsupra combines two medications in a single inhaler, patients may also benefit from simplified rescue treatment during asthma flare-ups. Treatment plans and inhaler use recommendations should always follow healthcare provider instructions and individualized asthma management plans.

 

Important Safety Information and Side Effects

Patients using Airsupra should not exceed the recommended maximum daily dose. Excessive use of albuterol-containing medications may increase the risk of serious heart-related side effects, including increased heart rate, elevated blood pressure, and abnormal heart rhythms.

Because Airsupra contains budesonide, an inhaled corticosteroid, patients may have an increased risk of oral fungal infections such as thrush. Rinsing the mouth after inhalation may help reduce this risk.

Rare paradoxical bronchospasm, which involves worsening breathing problems immediately after inhalation, may occur and can become life-threatening. Patients should seek medical attention if breathing worsens after using the inhaler.

Patients with certain heart conditions, seizures, thyroid disease, diabetes, or high blood pressure should discuss potential risks and safety considerations with their healthcare provider before using Airsupra. Allergic or hypersensitivity reactions, including anaphylaxis, may also occur.

Common side effects may include:

• Cough
• Hoarseness
• Headache
• Oral thrush
• Upper respiratory irritation
• Tremor or shakiness
• Fast heartbeat
• Nausea

Patients should seek medical attention if asthma symptoms worsen, rescue inhaler use increases significantly, or breathing does not improve after use.

Individuals should always speak with their healthcare provider regarding the risks, benefits, and safety considerations associated with Airsupra treatment.

 

Access to Multiple Medications

Those who deal with chronic asthma often rely on multiple inhalers, allergy medications, and even long-term respiratory therapies.

This means several prescriptions and paying for all the medications. For some, having several medications results in thousands of dollars spent out-of-pocket…every month.

Prescription Hope doesn’t just handle a single medication for you. For every medication you qualify for, we can provide the same great service for each one.

That means that whether it’s one or several, our service rate remains $70.00 per month, per med, no matter how complex the access to the patient assistance program is.

 

Why Choose Prescription Hope for Airsupra Assistance

Experienced Advocacy Support

For 20 years, our trained staff has helped Americans across the nation save hundreds of millions of dollars on their monthly medication costs.

Ongoing Medication Management

We don’t just fill out your forms. We advocate on your behalf with the patient assistance programs, manufacturers, and more. We continue to manage your account for as long as you’re a patient with us.

Transparent Monthly Pricing

$70.00 per month, per medication. We don’t hide fees, offer complex pricing systems, or shift our prices with the volatility of the medication retail market.

Nationwide Medication Access Support

Prescription Hope has worked with patients across the nation, hundreds of pharmaceutical manufacturers, thousands of medications, tens of thousands of healthcare providers, and supported hundreds of millions in savings.

If you’re looking for access to affordable Airsupra and are interested in applying for the Airsupra Patient Assistance Program, simply fill out our enrollment form today!